Medical News

RSS

Results from Keryx' KRX-0401 Phase 2 study to be presented at the International Kidney Cancer Symposium

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Phase 2 data of KRX-0401 (perifosine), the Company's PI3K/Akt pathway inhibitor for cancer, as a single agent in the treatment of advanced metastatic renal cell cancer, has been selected for oral presentation at the Eighth International Kidney Cancer Symposium, to be held in Chicago from September 25-26, 2009.

14 Sep 2009

Lobbyists ramp up efforts to shape health care reform

The St. Louis Post-Dispatch/New York Times reports: "Top lobbyists for every major sector of the health care industry publicly insist they are squarely behind the health care reform effort of President Barack Obama's administration.

14 Sep 2009

New data confirm link between Epstein-Barr virus and multiple sclerosis

Over the last 40 years, Epstein-Barr virus (EBV) has been repeatedly associated with multiple sclerosis and other autoimmune diseases. During the 2nd European Congress of Immunology ECI 2009 held in Berlin, Francesca Aloisi, Istituto Superiore di Sanità, Rome, will present new data that further support the link. In the brain lesions of patients with multiple sclerosis her team found abnormal accumulation of EBV infected B lymphocytes.

14 Sep 2009

Cytrx initiates tamibarotene and TRISENOX combination dose escalation study

CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced the initiation of a dose escalation study with its oncology drug candidate tamibarotene combined with TRISENOX® (arsenic trioxide) injection (marketed by Cephalon, Inc.) in patients with relapsed acute promyelocytic leukemia (APL).

14 Sep 2009

Malnutrition, poor sanitary conditions and HIV leads to defective immune system

The most common causes worldwide include malnutrition, poor sanitary conditions and human immune deficiency virus (HIV) infection. Other causes of temporary or permanent damage to the immune system include old age, medications (e.g. cortisone, cytostatic drugs), radiotherapy, stress after surgery and malignant tumors of the bone marrow and the lymph nodes.

14 Sep 2009

Celldex commences dosing patients in Phase 1/2 study of its CDX-1401 vaccine candidate

Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that the first patient has been dosed in a Phase 1/2 study of its vaccine candidate, CDX-1401, in patients with malignant solid tumors that express NY-ESO-1. CDX-1401 is a fully human monoclonal antibody designed to selectively deliver the NY-ESO-1 antigen to dendritic cells to generate a robust immune response against cancer cells expressing NY-ESO-1.

14 Sep 2009

Early vaccination minimizes the risk of damage by potentially harmful infections

Parents should not be worried, that early vaccination would overwhelm their babies. Recent data show, that the immune system of newborns is able to respond to a world full of antigens already at birth.

14 Sep 2009

Calypso’s GPS for the Body technology installed at University Of Maryland Greenebaum Cancer Center

Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, announced today that the University of Maryland Marlene and Stewart Greenebaum Cancer Center, a National Cancer Institute-designated cancer center in Baltimore, now offers the Calypso® System to provide accurate, precise, real-time tumor tracking for cancer patients undergoing external beam radiation therapy.

14 Sep 2009

Tips from ADT to prevent carbon monoxide poisoning

As Americans in many parts of the country gear up for colder weather, others brace for the peak of hurricane season. This means more families will begin using fuel-burning space heaters and portable generators that may release harmful carbon monoxide (CO) gas.

14 Sep 2009

Altair announces positive Phase I results for AIR645 in treating asthma

Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced positive results from a phase I multiple dose safety and pharmacokinetic study of its lead product, once-weekly inhaled AIR645 in healthy adults and mild asthmatics.

14 Sep 2009

Zabecor Pharmaceuticals initiates Phase II clinical trial of its Excellair asthma drug

ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.

14 Sep 2009

E-Health a forerunner of a health overhaul

CBS News reported on its program "Sunday Morning" that "what you may not know is that Congress has already approved and funded one program: the plan to computerize your medical records."

14 Sep 2009

Nonprofits seek financial relief in health legislation

The New York Times reports: "Nonprofit organizations say they are upset that Congress and the Obama administration have not addressed their rising health care costs in the various health care proposals being floated on Capitol Hill. The main bill in the House would award a tax credit to small businesses that provide their employees with health insurance — but nonprofits do not pay income taxes and thus would not benefit."

14 Sep 2009

Comparative effectiveness research may save money, but remains controversial

The Louisville Courier-Journal reports: "Democrats' plans for health care reform would try to provide answers with more studies on which drugs, medical devices and procedures work best for different patients. But while the goal of more 'comparative effectiveness' research may sound simple, getting there may be a challenge."

14 Sep 2009

Massage Envy clinics to donate funds to support breast cancer education

On Tuesday, September 15, at all Massage Envy clinics in the D.C. metro area, you can relax, get healthier, and help in the fight against breast cancer. All 18 area clinics in Maryland, D.C. and Virginia are offering massages at more than half-off the regular price, with $10 from each session being donated directly to area affiliates of Susan G. Komen for the Cure.

14 Sep 2009

Systech International announces new software for SPT application

Systech International, innovator of Packaging Execution Systems (PES) for the pharmaceutical industry, today announced the availability of a new software release for its widely-deployed Serialized Product Tracking (SPT) application.

14 Sep 2009

Positive results from Transave's Phase II clinical trial of ARIKACE in non-CF bronchiectasis patients

Transave, Inc., today reported positive results from a Phase II clinical trial in non-cystic fibrosis (CF) bronchiectasis patients for its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation). The Phase II data indicated that ARIKACE, delivered once daily for 28 consecutive days, demonstrated superior clinical benefit compared to placebo as measured by patient and physician reported outcomes and reduction in Pseudomonas aeruginosa density.

14 Sep 2009

Four additional patents increase SPO Medical's intellectual property portfolio to eight patents

SPO Medical Inc. (SPOM)s intellectual property (IP) portfolio to a total of eight patents. These latest patents, developed by the SPO Medical engineering team, increases the Company's technological competitive edge in providing innovative, high performance oximetry solutions for a variety of market applications.

14 Sep 2009

Corventis' AVIVO Mobile Patient Management System receives the CE mark

Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company’s AVIVO™ Mobile Patient Management System. Physicians and patients in the European Union and other countries that accept CE Mark now have access to the company’s noninvasive, wireless solution to evaluate physiological changes and monitor signs of cardiac irregularities in patients away from the hospital.

14 Sep 2009

ALR Technologies receives patent application approval for its Health-E-Connect communications system

ALR Technologies (OTCBB: ALRT) announces that it has received notice from the US Patent and Trademark Office that ALRT has been granted approval of its patent application regarding patient compliance and remote monitoring of patient's use of nebulizer compressors.

14 Sep 2009

Medical News

Results from Keryx' KRX-0401 Phase 2 study to be presented at the International Kidney Cancer Symposium

Lobbyists ramp up efforts to shape health care reform

New data confirm link between Epstein-Barr virus and multiple sclerosis

Cytrx initiates tamibarotene and TRISENOX combination dose escalation study

Malnutrition, poor sanitary conditions and HIV leads to defective immune system

Celldex commences dosing patients in Phase 1/2 study of its CDX-1401 vaccine candidate

Early vaccination minimizes the risk of damage by potentially harmful infections

Calypso’s GPS for the Body technology installed at University Of Maryland Greenebaum Cancer Center

Tips from ADT to prevent carbon monoxide poisoning

Altair announces positive Phase I results for AIR645 in treating asthma

Zabecor Pharmaceuticals initiates Phase II clinical trial of its Excellair asthma drug

E-Health a forerunner of a health overhaul

Nonprofits seek financial relief in health legislation

Comparative effectiveness research may save money, but remains controversial

Massage Envy clinics to donate funds to support breast cancer education

Systech International announces new software for SPT application

Positive results from Transave's Phase II clinical trial of ARIKACE in non-CF bronchiectasis patients

Four additional patents increase SPO Medical's intellectual property portfolio to eight patents

Corventis' AVIVO Mobile Patient Management System receives the CE mark

ALR Technologies receives patent application approval for its Health-E-Connect communications system

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Latest News